Mahmoud, Zainab
Orji, Ikechukwu A.
Shedul, Gabriel L.
Aluka-Omitiran, Kasarachi
Ripiye, Nanna
Akor, Blessing
Eze, Helen
Ojo, Tunde
Iyer, Guhan
Baldridge, Abigail S.
Hirschhorn, Lisa R.
Huffman, Mark D.
Ojji, Dike B.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (RO1HL144708)
Article History
Received: 30 January 2023
Accepted: 20 May 2023
First Online: 3 June 2023
Declarations
:
: ZM receives grant funding from the American College of Cardiology, Association of Black Cardiologists and Merck Foundation. MDH has pending patents for heart failure polypills. George Health Enterprises Pty Ltd (GH) and its subsidiary, George Medicines Pty Ltd, have received investment funds to develop fixed-dose combination products, including combinations of blood pressure-lowering drugs. GH is the social enterprise arm of The George Institute for Global Health. The remaining authors have nothing to disclose.
: All procedures followed were in accordance with the ethical standards of the ethics committees and institutional review board and the Helsinki Declaration of 1975, as revised in 2000. Patient informed consent was waived based on the Common Rule and this was approved by the ethics boards of University of Abuja Teaching Hospital, Federal Capital Territory of Nigeria, and Northwestern University. The study protocol was reviewed and approved by the ethics boards of University of Abuja Teaching Hospital, Federal Capital Territory of Nigeria, and Northwestern University, as well as the program’s Data and Safety Monitoring Board.
: Not Applicable.